G
Grigory Tsaur
Researcher at Boston Children's Hospital
Publications - 48
Citations - 1017
Grigory Tsaur is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Minimal residual disease & Medicine. The author has an hindex of 7, co-authored 38 publications receiving 848 citations. Previous affiliations of Grigory Tsaur include Ural Federal University.
Papers
More filters
Journal ArticleDOI
The MLL recombinome of acute leukemias in 2013
Claus Meyer,Julia Hofmann,Thomas Burmeister,Daniela Gröger,T S Park,Mariana Emerenciano,M. Pombo De Oliveira,Aline Renneville,Patrick Villarese,Elizabeth Macintyre,Hélène Cavé,Emmanuelle Clappier,K. Mass-Malo,Jan Zuna,Jan Trka,E De Braekeleer,M. De Braekeleer,S H Oh,Grigory Tsaur,L Fechina,V H J van der Velden,J J M van Dongen,Eric Delabesse,Renata Binato,Mara Silva,AM Kustanovich,Olga V. Aleinikova,Marian H. Harris,T Lund-Aho,Vesa Juvonen,Olaf Heidenreich,Josef Vormoor,William W.L. Choi,Marie Jarošová,A. Kolenova,Clara Bueno,Pablo Menendez,S. Wehner,Cornelia Eckert,Pascaline Talmant,Sylvie Tondeur,Eric Lippert,E. Launay,Catherine Henry,Paola Ballerini,H. Lapillone,Mary Callanan,Jean Michel Cayuela,Charles Herbaux,Giovanni Cazzaniga,P. M. Kakadiya,Stefan K. Bohlander,Martina Ahlmann,Jong Rak Choi,Paula Gameiro,Dongsoon Lee,Juergen Krauter,Pascale Cornillet-Lefebvre,G te Kronnie,Beat W. Schäfer,S. Kubetzko,Cristina N. Alonso,U. Zur Stadt,Rosemary Sutton,N. C. Venn,Shai Izraeli,Luba Trakhtenbrot,H. O. Madsen,P. Archer,Jeremy Hancock,Nuno Cerveira,Manuel R. Teixeira,L Lo Nigro,Anja Möricke,Martin Stanulla,Martin Schrappe,Lukasz Sedek,Tomasz Szczepański,Christian M. Zwaan,Eva A. Coenen,M.M. van den Heuvel-Eibrink,Sabine Strehl,Michael Dworzak,Renate Panzer-Grümayer,Theodor Dingermann,Thomas Klingebiel,Rolf Marschalek +86 more
TL;DR: Long-distance inverse-polymerase chain reaction was used to characterize the chromosomal rearrangement of individual acute leukemia patients and revealed a total of 121 different MLL rearrangements, of which 79 TPGs are now characterized at the molecular level.
Journal ArticleDOI
New insights to the MLL recombinome of acute leukemias
Christian Meyer,Eric Kowarz,Julia Hofmann,Aline Renneville,Jan Zuna,Jan Trka,R. Ben Abdelali,Elizabeth Macintyre,E De Braekeleer,E De Braekeleer,M. De Braekeleer,M. De Braekeleer,Eric Delabesse,M. P. de Oliveira,Hélène Cavé,Emmanuelle Clappier,J J M van Dongen,Brian V. Balgobind,M M van den Heuvel-Eibrink,H B Beverloo,Renate Panzer-Grümayer,Andrea Teigler-Schlegel,Jochen Harbott,Eigil Kjeldsen,Susanne Schnittger,Ulrike Koehl,Bernd Gruhn,Olaf Heidenreich,Li Chong Chan,Sze-Fai Yip,Martin Krzywinski,C Eckert,Anja Möricke,Martin Schrappe,Cristina N. Alonso,Beat W. Schäfer,Jürgen Krauter,Dean A. Lee,U zur Stadt,G te Kronnie,Rosemary Sutton,Shai Izraeli,L. Trakhtenbrot,L. Trakhtenbrot,L Lo Nigro,Grigory Tsaur,Larisa Fechina,Tomasz Szczepański,Sabine Strehl,D. Ilencikova,Mara Molkentin,Thomas Burmeister,Theodor Dingermann,T. Klingebiel,Rolf Marschalek +54 more
TL;DR: In this paper, the distribution of MLL breakpoints for clinical subtypes (acute lymphoblastic leukemia, acute myeloid leukemia, pediatric and adult) and fused translocation partner genes (TPGs) were presented, including novel MLL fusion genes.
Journal ArticleDOI
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL.
Lina Hamadeh,Amir Enshaei,Claire Schwab,Cristina N. Alonso,Andishe Attarbaschi,Gisela Barbany,Monique L. den Boer,Judith M. Boer,Marcin Braun,Luciano Dalla Pozza,Sarah Elitzur,Mariana Emerenciano,Larisa Fechina,Maria S. Felice,Eva Fronkova,Irén Haltrich,Mats Heyman,Keizo Horibe,Toshihiko Imamura,Marta Jeison,Gabor G. Kovacs,Roland P. Kuiper,Wojciech Młynarski,Karin Nebral,Ingegerd Ivanov Öfverholm,Agata Pastorczak,Rob Pieters,Henriett Pikó,Maria S. Pombo-de-Oliveira,Patricia L. Rubio,Sabine Strehl,Jan Stary,Rosemary Sutton,Jan Trka,Grigory Tsaur,Nicola C. Venn,Ajay Vora,Mio Yano,Christine J. Harrison,Anthony V. Moorman +39 more
TL;DR: The UKALL-CNA classifier is a robust prognostic tool that can be deployed in different trial settings and used to refine established cytogenetic risk groups.
Journal ArticleDOI
Absolute count of leukemic blasts in cerebrospinal fluid as detected by flow cytometry is a relevant prognostic factor in children with acute lymphoblastic leukemia
Alexander Popov,Guenter Henze,Tatiana Verzhbitskaya,Julia Roumiantseva,Svetlana Lagoyko,Olga Khlebnikova,Olga Streneva,Oleg Bidanov,Grigory Tsaur,Hiroto Inaba,Alexander Karachunskiy,Larisa Fechina +11 more
TL;DR: The data do not support the concept of re-stratification and modification of therapy based on qualitative CSF investigation by MFC, however, MFC is a highly sensitive technique ofCSF investigation improving the definition of CNS involvement in childhood ALL, and quantitative measurement of blast cells in CSF, if well-organized, can be a useful additional tool for stratification of patients in clinical trials.
Journal ArticleDOI
Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy
Alexandra Semchenkova,Ekaterina Mikhailova,A Komkov,Marina Gaskova,R. Abasov,Evgenii V. Matveev,Marat D. Kazanov,Ilgar Z. Mamedov,A. D. Shmitko,V. Belova,Anna M Miroshnichenkova,Olga Illarionova,Yulia Olshanskaya,Grigory Tsaur,Tatiana Verzhbitskaya,Natalia Ponomareva,G. O. Bronin,Konstantin Kondratchik,L Fechina,Yulia Diakonova,L. N. Vavilova,N.V. Myakova,Galina Novichkova,Alexey Maschan,Michael Maschan,Elena Zerkalenkova,Alexander Popov +26 more
TL;DR: The presented cases showed consistency of gene rearrangements and fusion transcripts across initially diagnosed leukemia and lineage switch, and in two of six patients, the clonal architecture assessed by IG/TR gene rearranged was stable, while in others, loss of clones or gain of new clones was noted.